197 related articles for article (PubMed ID: 31843938)
1. In situ self-assembling Au-DNA complexes for targeted cancer bioimaging and inhibition.
Wang M; Chen Y; Cai W; Feng H; Du T; Liu W; Jiang H; Pasquarelli A; Weizmann Y; Wang X
Proc Natl Acad Sci U S A; 2020 Jan; 117(1):308-316. PubMed ID: 31843938
[TBL] [Abstract][Full Text] [Related]
2. Precise therapeutic effect of self-assembling gold nanocluster-PTEN complexes on an orthotropic model of liver cancer.
Wang M; Wang L; Feng H; Jiang H; Zhou J; Wang X
J Cancer Res Clin Oncol; 2020 Apr; 146(4):875-882. PubMed ID: 32107624
[TBL] [Abstract][Full Text] [Related]
3. DNA Polymer Nanoparticles Programmed via Supersandwich Hybridization for Imaging and Therapy of Cancer Cells.
Li N; Xiang MH; Liu JW; Tang H; Jiang JH
Anal Chem; 2018 Nov; 90(21):12951-12958. PubMed ID: 30303006
[TBL] [Abstract][Full Text] [Related]
4. A multifunctional theranostic contrast agent for ultrasound/near infrared fluorescence imaging-based tumor diagnosis and ultrasound-triggered combined photothermal and gene therapy.
Wang L; Lu H; Gao Q; Yuan C; Ding F; Li J; Zhang D; Ou X
Acta Biomater; 2019 Nov; 99():373-386. PubMed ID: 31525534
[TBL] [Abstract][Full Text] [Related]
5. Gold Nanoparticles as Targeted Delivery Systems and Theranostic Agents in Cancer Therapy.
Mioc A; Mioc M; Ghiulai R; Voicu M; Racoviceanu R; Trandafirescu C; Dehelean C; Coricovac D; Soica C
Curr Med Chem; 2019; 26(35):6493-6513. PubMed ID: 31057102
[TBL] [Abstract][Full Text] [Related]
6. In situ biosynthesized gold nanoclusters inhibiting cancer development via the PI3K-AKT signaling pathway.
Wang M; Yu Z; Feng H; Wang J; Wang L; Zhang Y; Yin L; Du Y; Jiang H; Wang X; Zhou J
J Mater Chem B; 2019 Sep; 7(35):5336-5344. PubMed ID: 31393501
[TBL] [Abstract][Full Text] [Related]
7. In Situ Biosynthesis of Fluorescent Platinum Nanoclusters: Toward Self-Bioimaging-Guided Cancer Theranostics.
Chen D; Zhao C; Ye J; Li Q; Liu X; Su M; Jiang H; Amatore C; Selke M; Wang X
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18163-9. PubMed ID: 26227621
[TBL] [Abstract][Full Text] [Related]
8. Carbon-gold hybrid nanoprobes for real-time imaging, photothermal/photodynamic and nanozyme oxidative therapy.
Zhang A; Pan S; Zhang Y; Chang J; Cheng J; Huang Z; Li T; Zhang C; de la Fuentea JM; Zhang Q; Cui D
Theranostics; 2019; 9(12):3443-3458. PubMed ID: 31281489
[No Abstract] [Full Text] [Related]
9. Cisplatin Prodrug-Conjugated Gold Nanocluster for Fluorescence Imaging and Targeted Therapy of the Breast Cancer.
Zhou F; Feng B; Yu H; Wang D; Wang T; Liu J; Meng Q; Wang S; Zhang P; Zhang Z; Li Y
Theranostics; 2016; 6(5):679-87. PubMed ID: 27022415
[TBL] [Abstract][Full Text] [Related]
10. Lanthanide (Gd(3+) and Yb(3+)) functionalized gold nanoparticles for in vivo imaging and therapy.
Ge X; Song ZM; Sun L; Yang YF; Shi L; Si R; Ren W; Qiu X; Wang H
Biomaterials; 2016 Nov; 108():35-43. PubMed ID: 27619238
[TBL] [Abstract][Full Text] [Related]
11. A challenge for theranostics: is the optimal particle for therapy also optimal for diagnostics?
Dreifuss T; Betzer O; Shilo M; Popovtzer A; Motiei M; Popovtzer R
Nanoscale; 2015 Oct; 7(37):15175-84. PubMed ID: 26313344
[TBL] [Abstract][Full Text] [Related]
12. Current Perspective in Cancer Theranostics Based on Gold Nanoparticles.
Chatterjee S; Liang F
Anticancer Agents Med Chem; 2022; 22(13):2354-2357. PubMed ID: 35196973
[TBL] [Abstract][Full Text] [Related]
13. pH-responsive unimolecular micelle-gold nanoparticles-drug nanohybrid system for cancer theranostics.
Lin W; Yao N; Qian L; Zhang X; Chen Q; Wang J; Zhang L
Acta Biomater; 2017 Aug; 58():455-465. PubMed ID: 28583900
[TBL] [Abstract][Full Text] [Related]
14. Bioresponsive antisense DNA gold nanobeacons as a hybrid in vivo theranostics platform for the inhibition of cancer cells and metastasis.
Bao C; Conde J; Curtin J; Artzi N; Tian F; Cui D
Sci Rep; 2015 Jul; 5():12297. PubMed ID: 26189409
[TBL] [Abstract][Full Text] [Related]
15. Intelligent Bio-Responsive Fluorescent Au-shRNA Complexes for Regulated Autophagy and Effective Cancer Bioimaging and Therapeutics.
Cai W; Yin L; Jiang H; Weizmann Y; Wang X
Biosensors (Basel); 2021 Oct; 11(11):. PubMed ID: 34821640
[TBL] [Abstract][Full Text] [Related]
16. Engineering Liganded Gold Nanoclusters as Efficient Theranostic Agents for Cancer Applications.
Bonačić-Koutecký V; Le Guével X; Antoine R
Chembiochem; 2023 Feb; 24(4):e202200524. PubMed ID: 36285807
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional gold-based nanocomposites for theranostics.
Dykman LA; Khlebtsov NG
Biomaterials; 2016 Nov; 108():13-34. PubMed ID: 27614818
[TBL] [Abstract][Full Text] [Related]
18. Gold nanoparticles enlighten the future of cancer theranostics.
Guo J; Rahme K; He Y; Li LL; Holmes JD; O'Driscoll CM
Int J Nanomedicine; 2017; 12():6131-6152. PubMed ID: 28883725
[TBL] [Abstract][Full Text] [Related]
19. Gold-based Inorganic Nanohybrids for Nanomedicine Applications.
Ding X; Li D; Jiang J
Theranostics; 2020; 10(18):8061-8079. PubMed ID: 32724458
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-Loaded Unimolecular Micelle-Stabilized Gold Nanoparticles as a Theranostic Nanoplatform for Tumor-Targeted Chemotherapy and Computed Tomography Imaging.
Lin W; Zhang X; Qian L; Yao N; Pan Y; Zhang L
Biomacromolecules; 2017 Dec; 18(12):3869-3880. PubMed ID: 29032674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
